iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Concord Biotech to announce IPO allotment today; here’s how to check

11 Aug 2023 , 09:40 AM

Concord Biotech, backed by Rekha Jhunjhunwala, is expected to disclose the allotment of shares from its initial public offering (IPO) today, August 11, following the IPO’s tentative timeline. 

Those who participated in the Concord IPO can access their application’s allotment status online through the BSE website or the registrar’s site, Link Intime India Private Limited.

According to BSE data, Concord Biotech’s Rs 1551 crore IPO was oversubscribed by 25 times on the final day of the offering. The qualified institutional buyers (QIB) segment was oversubscribed by 68 times, the non-institutional investors’ segment by 17 times, and retail investors bid for 3.78 times the allocated shares.

The biopharma company, specializing in the production of active pharmaceutical ingredients (API), initiated its public offering for subscription on Friday. The pricing for the offering ranged from Rs 705 to Rs 741 per share. The entire public issue comprises the sale of up to 2.09 crore shares by existing shareholders. Notably, three trusts affiliated with the Jhunjhunwala family – Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust, and Nishtha Jhunjhunwala Discretionary Trust – collectively hold an 8.03% stake each in the company.

Before the commencement of its initial public offering, the company secured a substantial amount of Rs 464.95 crore from anchor investors. This was achieved by allocating a total of 62.75 lakh shares to these investors. The prominent bankers overseeing the issue are Kotak Mahindra Capital Company, Citigroup Global Markets India, and Jefferies India.

 

Concord Biotech to announce IPO allotment today; here’s how to check

Related Tags

  • Concord Biotech
  • Concord Biotech ipo
  • Concord Biotech IPO allotment
  • Concord Biotech IPO details
  • Concord Biotech IPO listing
  • IPO details
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.